Equillium, Inc. Cash Flow Statement
EQ|4 years of annual SEC 10-K data (FY2022-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 4 fiscal years. All figures from audited SEC 10-K filings.
Equillium, Inc. used $19M in operating cash flow and negative free cash flow of $19M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income | -$8.1M | -$13.3M | -$62.4M | -$39.1M |
| Depreciation & Amortization | $137.0K | $126.0K | $118.0K | $72.0K |
| Operating Cash Flow | -$19.0M | -$21.8M | -$8.7M | -$32.1M |
| Capital Expenditures | $85.0K | $50.0K | $279.0K | $57.0K |
| Free Cash Flow | -$19.1M | -$21.8M | -$9.0M | -$32.1M |
| Share Buybacks | - | $260.0K | $260.0K | - |
| FCF Margin | -46.5% | -60.5% | -57.2% | -203.9% |